Oxcarbazepine
From the Halo Fan Fiction Wikia, writing 13,088 fan fiction articles
|
This article, Oxcarbazepine, was written by RelentlessRecusant. Please do not edit this fiction without the writer's permission. |
| [Source] | |
Oxcarbazepine (OCZ), IUPAC name 10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide, is a small-molecule chemical modulator of central nervous sodium (Na+) channels[1], likely Nav1.1 (SCN1A) and Nav1.2 (SCN2A) and is an inhibitor of the fast Na+ conductance current (INaF). It is an oxidated heterocyclic derivative of carbamazepine, a carbamoyl derivative of iminodibenzyls.[2]
It is marketed primarily as an anti-epileptic drug (AED) because of its neuromodulatory effects on the central fast Na+ current, although oxcarbazepine has a broad activity against other non-epileptic central neurological pathologies, including neuropathic pain, trigeminal neuralgia, maniac effective bipolar disorder, and alcohol withdrawal.[2]
Oxcarbazepine's activity is mediated by its main human metabolite; monohydroxy metabolite (MHD).[3]
[edit] References
- ↑ Rogawski and Löscher (2004). The Neurobiology of Antiepileptic Drugs. Nature Reviews Neuroscience (5): 553-564.
- ↑ 2.0 2.1 Rogawski and Löscher (2004). The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Medicine (10): 685-692.
- ↑ Schmutz et. al (1991). Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia (35): S47-50.
| Chemical Biology: Small-Molecule Control of Biological Systems (RelentlessRecusant) | ||
|---|---|---|
| | ||
| Receptor Tyrosine Kinases | A-83-01 (TGFβ/Activin) · BPIQ-II (EGFR) · Dorsomorphin/LDN-193189 (TGFβ/BMP) · SU5402 (FGFR) | |
| Signaling Kinases | A-769662 (AMPK) · BMS-354825 (BCR-ABL, Src)· BIO-Acetoxime (GSK3) · CHIR99021 (GSK3) · GO 6976 (PKC) · IMD-0354 (IκBa) · PD184352 (MAPK) · SB203580 (MAPK) · Y-27632 (ROCK) | |
| G Protein-Coupled Receptor | (+)-WIN-55212 (CB1/CB2) · ±-Sulpride (D2) · A 841720 (mGluR1) · BP-554 (5-HT1A) · Hh-Ag1.5 (Smo) · Cyclopamine/KAAD-Cyclopamine (Smo) · SANT1 (Smo) · SB-277011 (D3) | |
| Ion Channels | BAY K8644 (Cav1.2) · Bicuculline (GABAAR) · Cymarin (Na+/H+) · G-strophanthin (Na+/H+) · L-AP4 (Na+/H+) · Oxcarbazepine (Na+) · Resiniferatoxin (TRPV1) · Sarmentogenin (Na+/H+) · Theanine (AMPAR, NMDAR) | |
| Transporters | O-1783 (DAT) · WF-23 (DAT, SERT) | |
| Nuclear Receptor | All-trans retinoic acid (RAR/RXR) · GW501516 (PPARδ) · RU-486 (Nr3c1, Nr3c3) | |
| Protein Phosphatases | Endothall (PP2A) | |
| Polypharmacological | Phosphoserine (mGluR4) · PK115-584 (Tcf4/β-catenin, PKC) · Pluripotin · Reversine | |
| Other | 2C-E (DAT) · 4-methoxyphenyl-HTI-286 (α/β-tubulin) · Compound E/DAPT (presenilin-1) · D-cysteine · D-phenylalanine · Flurbiprofen (COX) · JZL184 (MAGL) · QS11 (RAFGAP1) · RO-28-1675 (glucokinase) · Robotnikinin (Shh) · Selegiline (MAOB) | |
| Uncharacterized | Neuropathiazol | |
| Libraries | Kinase Inhibitor Library | |
| Publications | ||
| Small molecule-mediated manipulation of the adult human induces selective and reversible control of physiological and psychological phenotype (Rubin et. al, 2590. Nature Medicine) | ||
| Source · Edit | ||
.jpg)


